GL0034 (Utreglutide), a novel, long acting, glucagon-like peptide 1 receptor agonist (GLP-1 RA), results of a phase 1 study in healthy individuals

被引：0
|
作者：
Thennati, Rajamannar [1 ]
Burade, Vinod [1 ]
Natarajan, Muthukumaran [1 ]
Shahi, Pradeep [1 ]
Nagaraja, Ravishankara [1 ]
Panchal, Satish [1 ]
Agrawal, Sudeep [1 ]
Jandrain, Bernard [2 ]
Duvauchelle, Thierry [3 ]
Pratley, Richard E. [4 ]
Thorens, Bernard [5 ]
Vilsboll, Tina [6 ]
机构：
[1] Sun Pharmaceut Ind Ltd, High Impact Innovat Sustainable Hlth Solut HISHS, Vadodara, India
[2] Acad Hosp Liege, ATC Co, Clin Pharmacol Unit, Nutr & Metab Disorders, Liege, Belgium
[3] Phaster1, Paris, France
[4] AdventHlth Translat Res Inst, Orlando, FL USA
[5] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland
[6] Univ Copenhagen, Steno Diabet Ctr, Clin Res, Copenhagen, Denmark
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-419
引用
收藏
页码：S607 / S608
页数：2
相关论文
共 50 条
  • [1] A Single Ascending Dose Study of the Novel GLP-1 Receptor Agonist GL0034 (Utreglutide) in Obese Individuals without Diabetes
    Thennati, Rajamannar
    Burade, Vinod S.
    Natarajan, Muthukumaran
    Shahi, Pradeep
    Nagaraja, Ravishankara
    Panchal, Satish T.
    Agrawal, Sudeep K.
    Jandrain, Bernard
    Duvauchelle, Thierry
    Garcia-Ocana, Adolfo
    Rutter, Guy A.
    Pratley, Richard E.
    Thorens, Bernard
    Vilsboll, Tina
    DIABETES, 2023, 72
  • [2] A single ascending dose study of the novel GLP-1 receptor agonist GL0034 (utreglutide) in individuals with obesity without diabetes
    Thennati, R.
    Burade, V.
    Natarajan, M.
    Shahi, P.
    Nagaraja, R.
    Panchal, S.
    Agrawal, S.
    Jandrain, B.
    Duvauchelle, T.
    Garcia-Ocana, A.
    Rutter, G. A.
    Pratley, R. E.
    Thorens, B.
    Vilsboll, T.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S320 - S321
  • [3] In vivo and in vitro characterization of GL0034, a novel long-acting glucagon-like peptide-1 receptor agonist
    Jones, Ben
    Burade, Vinod
    Akalestou, Elina
    Manchanda, Yusman
    Ramchunder, Zenouska
    Carrat, Gaelle
    Nguyen-Tu, Marie-Sophie
    Marchetti, Piero
    Piemonti, Lorenzo
    Leclerc, Isabelle
    Thennati, Rajamannar
    Vilsboll, Tina
    Thorens, Bernard
    Tomas, Alejandra
    Rutter, Guy A.
    DIABETES OBESITY & METABOLISM, 2022, 24 (11): : 2090 - 2101
  • [4] GL0034 (Utreglutide), a long acting, glucagon-like peptide-1 receptor agonist, improves body weight loss, lipid and liver injury markers in individuals with obesity: A phase 1 multiple ascending dose study
    Thennati, Rajamannar
    Burade, Vinod
    Natarajan, Muthukumaran
    Shahi, Pradeep
    Nagaraja, Ravishankara
    Agrawal, Sudeep
    Jandrain, Bernard
    Duvauchelle, Thierry
    Pratley, Richard E.
    Thorens, Bernard
    Vilsboll, Tina
    Loomba, Rohit
    JOURNAL OF HEPATOLOGY, 2024, 80 : S615 - S616
  • [5] Glucagon-Like Peptide 1 Receptor Agonist (GLP-1 RA) Delays Cyst Growth in ADPKD
    Wu Jiao
    Cheng Shasha
    Zhang Yingying
    Li Xiaoyan
    Zhou Xia
    Li Xiaogang
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [6] Insulin and glucagon-like peptide receptor agonist (GLP 1 RA) combinations
    Kalra, Sanjay
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2014, 64 (03) : 359 - 361
  • [7] Glucagon-like peptide 1 (GLP-1)
    Mueller, T. D.
    Finan, B.
    Bloom, S. R.
    D'Alessio, D.
    Drucker, D. J.
    Flatt, P. R.
    Fritsche, A.
    Gribble, F.
    Grill, H. J.
    Habener, J. F.
    Holst, J. J.
    Langhans, W.
    Meier, J. J.
    Nauck, M. A.
    Perez-Tilve, D.
    Pocai, A.
    Reimann, F.
    Sandoval, D. A.
    Schwartz, T. W.
    Seeley, R. J.
    Stemmer, K.
    Tang-Christensen, M.
    Woods, S. C.
    DiMarchi, R. D.
    Tschoep, M. H.
    MOLECULAR METABOLISM, 2019, 30 : 72 - 130
  • [8] A Phase 1 Single Ascending Dose Study of the Novel GLP-1R Agonist GL0034 in Subjects With Obesity
    Thennati, Rajamannar
    Burade, Vinod
    Natarajan, Muthukumar
    Shahi, Pradeep
    Nagaraja, Ravishankara
    Panchal, Satish
    Agrawal, Sudeep
    Jandrain, Bernard
    Duvauchelle, Thierry
    Pratley, Richard
    Thorens, Bernard
    Vilsboll, Tina
    OBESITY, 2023, 31 : 284 - 284
  • [9] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [10] The GLP-1 receptor agonist GL0034 activates central regions controlling glucose homeostasis and feeding behaviour
    Picard, A.
    Tarussio, D.
    Thennati, R.
    Burade, V.
    Thorens, B.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S278 - S279
12345